Holen Sie sich die Stockscreener-App
1.45
0.68%
-0.01
Handel nachbörslich:
1.44
-0.01
-0.69%
Schlusskurs vom Vortag:
$1.46
Offen:
$1.5
24-Stunden-Volumen:
641.93K
Relative Volume:
0.99
Marktkapitalisierung:
$22.05M
Einnahmen:
$486.00K
Nettoeinkommen (Verlust:
$-28.43M
KGV:
-0.5144
EPS:
-2.8189
Netto-Cashflow:
$-26.75M
1W Leistung:
+19.83%
1M Leistung:
+2.11%
6M Leistung:
-46.30%
1J Leistung:
-30.62%
1-Tages-Spanne:
$1.4102
$1.595
1-Wochen-Bereich:
$1.12
$1.595
52-Wochen-Spanne:
$0.85
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
1.45 | 24.33M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Published on: 2025-07-29 03:11:42 - metal.it
Vyne Therapeutics: A Risky Bet On Upcoming Vitiligo Ph2b Readout (NASDAQ:VYNE) - Seeking Alpha
What institutional investors are buying VYNE Therapeutics Inc. stockInvest smarter with data-backed trading alerts - jammulinksnews.com
How does VYNE Therapeutics Inc. generate profit in a changing economyFree Investment Case Studies - jammulinksnews.com
Order flow analysis tools used on VYNE Therapeutics Inc.Investment Position Summary with Timeframe Forecast - Newser
Real time pattern detection on VYNE Therapeutics Inc. stockReal-Time Equity Price Action Analysis - Newser
What makes VYNE Therapeutics Inc. stock price move sharply Growth Projection Summary for Long-Term Investors - Newser
What analysts say about VYNE Therapeutics Inc. stock outlook Free Buy Alerts With Low Risk Confirmation - Newser
How volatile is VYNE Therapeutics Inc. stock compared to the marketCapitalize on market momentum for maximum gains - jammulinksnews.com
How many analysts rate VYNE Therapeutics Inc. as a “Buy”Invest smarter with actionable stock recommendations - jammulinksnews.com
When is VYNE Therapeutics Inc. stock expected to show significant growthBuild a winning portfolio with smart picks - jammulinksnews.com
What analysts say about VYNE Therapeutics Inc. stock outlookFree Day Trading Recommendations - metal.it
What makes VYNE Therapeutics Inc. stock price move sharplySafe and Smart Investment Picks - metal.it
Is VYNE Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideBreakout Momentum Stocks - Newser
How Resilient Is VYNE Therapeutics Inc. Stock During Economic DownturnsReal Chart Play - Newser
How Efficient Is VYNE Therapeutics Inc. at Controlling Operating CostsFree Access to Community - Newser
How VYNE Therapeutics Inc. stock performs during market volatilityFree Elite Traders Group - Newser
Does VYNE Therapeutics Inc. stock pay reliable dividendsROI Focused Stock Calls - Newser
What drives VYNE Therapeutics Inc. stock priceOutperformance with explosive growth - PrintWeekIndia
Is VYNE Therapeutics Inc. a good long term investmentUnrivaled growth potential - PrintWeekIndia
What analysts say about VYNE Therapeutics Inc. stockExplosive capital gains - PrintWeekIndia
VYNE Therapeutics Inc. Stock Analysis and ForecastConsistently high yield - PrintWeekIndia
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):